EU Urged To Prioritize Clinical Strategy Talks In Pre-Submission Process

 
• By Amanda Maxwell

EU industry advocates for amendment to existing proposal to streamline clinical strategy costs and timelines, as well as boost efficiency and innovation

EU regulatory efficiency would be improved if companies had a clinical dialogue with notified bodies Shutterstock

More from Medtech Insight

More from Policy & Regulation